Penserra Capital Management LLC Clene Inc. Transaction History

Penserra Capital Management LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$2.1 - $4.12 $2,047 - $4,017	-975 Reduced 13.47%	6,265 $15,000
Q1 2022 May 13, 2022	BUY	$2.42 - $4.42 $4,005 - $7,315	1,655 Added 29.63%	7,240 $28,000
Q4 2021 Feb 15, 2022	BUY	$3.95 - $7.53 $1,702 - $3,245	431 Added 8.36%	5,585 $22,000
Q3 2021 Nov 15, 2021	SELL	$6.83 - $13.58 $19,731 - $39,232	-2,889 Reduced 35.92%	5,154 $35,000
Q2 2021 Aug 12, 2021	BUY	$6.98 - $13.33 $15,376 - $29,365	2,203 Added 37.72%	8,043 $90,000

Q1 2021 May 13, 2021	BUY	$6.39 - $16.3 $37,317 - $95,192	5,840 New	5,840 $74,000

7.44M

48.1K

160K

Ticker CLNN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 63,502,000
Market Cap $21M
Description
Clene Inc., a clinical-stage pharmaceutical company, focuses on the discovery, development, and commercialization of novel clean-surfaced nanotechnology (CSN) therapeutics. Its lead drug is CNM-Au8, which is being studied in various clinical trials, including a Phase 2/3 registrational clinical trial for patients with amyotrophic lateral scleros...

Get notified when there are updates to the investment portfolio of Penserra Capital Management LLC, based on Form 13F filings with the SEC.

Stay updated on Penserra Capital Management LLC with notifications on news.